1. Home
  2. FAF vs PCVX Comparison

FAF vs PCVX Comparison

Compare FAF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

N/A

Current Price

$65.74

Market Cap

6.3B

Sector

Finance

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$58.11

Market Cap

6.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAF
PCVX
Founded
1889
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.1B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
FAF
PCVX
Price
$65.74
$58.11
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$78.50
$98.33
AVG Volume (30 Days)
981.7K
1.1M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
3.36%
N/A
EPS Growth
376.19
N/A
EPS
6.00
N/A
Revenue
$7,452,200,000.00
N/A
Revenue This Year
$8.04
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
$10.93
N/A
Revenue Growth
21.61
N/A
52 Week Low
$53.95
$28.09
52 Week High
$71.47
$76.61

Technical Indicators

Market Signals
Indicator
FAF
PCVX
Relative Strength Index (RSI) 44.51 52.93
Support Level $64.27 $42.30
Resistance Level $66.10 $65.00
Average True Range (ATR) 1.92 3.08
MACD -0.37 -0.53
Stochastic Oscillator 12.35 35.38

Price Performance

Historical Comparison
FAF
PCVX

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: